Brandt provides insight on how the pharmacy profession can play a role in legal reform, regulatory policy creation, and pharmacy operations to broaden access to psychedelics while mitigating harm, using Canada as a case study.
INPUD, WHO and UNODC update WHO's Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care in relation to people who inject drugs.
C-EHRN outlines the importance of cooperation between
civil society organisations and state agencies, accompanied by adequate funding and a clear mandate for service providers in the face of a challenging and constantly changing harm reduction landscape.
Kammersgaard highlights how existing rationalities and practices associated with prohibition often remain intact in decriminalisation proposals, despite a push towards health and human rights.
CGHE and INHSU Prisons note that persons who are incarcerated experience the highest burdens of HCV globally and should therefore have the right to access HCV services, but they too often face systematic discrimination.
The EMCDDA present their findings of the largest European project to date in the emerging science of wastewater analysis, conducted in over 100 European cities and towns to explore the drug-taking habits of people who live in them.
WHRIN and ICW call for decriminalisation and the promotion of women's voices in decision-making forums, among many other recommendations, to address the challenges faced by women who live with HIV and use drugs.
IDPC sheds light on key political wins including in relation to countering racial discrimination in drug policy, recognising the importance of harm reduction for the right to health, protecting Indigenous rights, and promoting engagement by UN human rights bodies in drug policy debates.
UNODC provides insights into a booming market, highlighting a 35% increase in the global production of cocaine following an initial slowdown caused by the COVID-19 pandemic.
Czechia stresses the importance of an evidence-based, integrated, balanced drug policies rooted in the freedom of citizens, the protection of human rights, dignity and the rule of law.
Ghana discusses the first ever National Dialogue on the International Guidelines on Human Rights and Drug Policy, including identifying human rights priorities and integrating them in the national plans for reform.
